As of 2025-10-20, the Relative Valuation of Horizon Therapeutics PLC (HZNP) is 66.25 USD. This relative valuation is based on P/E multiples. With the latest stock price at 116.30 USD, the upside of Horizon Therapeutics PLC based on Relative Valuation is -43.0%.
The range of the Relative Valuation is 46.63 - 89.29 USD.
| Range | Selected | |
| Trailing P/E multiples | 32.0x - 46.7x | 38.5x |
| Forward P/E multiples | 20.3x - 31.4x | 25.6x |
| Fair Price | 46.63 - 89.29 | 66.25 |
| Upside | -59.9% - -23.2% | -43.0% |
| Date | P/E |